business restructuring actions, including the settlement of a long-term take-or-pay silane contract.
The current year payments were partially offset by a $69.7 net increase to accrued liabilities for the current year cost reduction and business restructuring actions.
For the year ended 2012, cash provided by operating activities was $1,765.1.
Income from continuing operations of $999.2 reflected the non-cash gain on the previously held equity interest in DA NanoMaterials of $85.9, the writedown of long-lived assets associated with restructuring and a customer bankruptcy of $80.2, and a non-cash tax benefit of $58.3 recognized as a result of the second quarter Spanish tax ruling.
The working capital accounts were a source of cash of $100.1.
The provision for the cost reduction and business restructuring plans resulted in an increase to accrued liabilities of $223.9, partially offset by a use of cash of $32.9 for payments made in relation to these plans.
For the year ended 2011, cash provided by operating activities was $1,710.4.
Income from continuing operations of $1,134.3 reflected the non-cash net loss of $48.5 related to the Airgas transaction.
We also made cash payments of $156.2 related to the Airgas transaction.
The working capital accounts were a use of cash of $114.6, including $107.5 for an increase in inventory primarily to support growth in our Performance Materials business.
Investing Activities For the year ended 30 September 2013, cash used for investing activities was $1,697.0, primarily driven by capital expenditures for plant and equipment and acquisitions.
For the year ended 30 September 2012, cash used for investing activities was $2,435.2, primarily driven by capital expenditures for plant and equipment, acquisitions, and investments in unconsolidated affiliates.
Refer to the Capital Expenditures section below for additional detail.
For the year ended 30 September 2011, cash used for investing activities was $1,169.8, primarily driven by capital expenditures for plant and equipment.
We received proceeds of $94.7 from the sale of approximately 1.5 million shares of Airgas stock.
Refer to Note 6, Airgas Transaction, to the consolidated financial statements for additional information regarding this transaction.
Capital Expenditures Capital expenditures are detailed in the following table:
## Table 0 ##
(A) We utilize a non-GAAP measure in the computation of capital expenditures and include spending associated with facilities accounted for as capital leases and purchases of noncontrolling interests.
Certain contracts associated with facilities that are built to provide product to a specific customer are required to be accounted for as leases, and such spending is reflected as a use of cash within cash provided by operating activities, if the arrangement qualifies as a capital lease.
Additionally, the purchase of noncontrolling interests in a subsidiary is accounted for as an equity transaction and will be reflected as a financing activity in the statement of cash flows.
The presentation of this non-GAAP measure is intended to enhance the usefulness of information by providing a measure that our management uses internally to evaluate and manage our expenditures.
Capital expenditures on a GAAP basis in 2013 totaled $1,747.8, compared to $2,559.8 in 2012, resulting in a decrease of $812.0, primarily due to the acquisition of Indura S. A.  in 2012.
Additions to plant and equipment are largely in support of the Merchant Gases and Tonnage Gases businesses.
Additions to plant and equipment also included support capital of a routine, ongoing nature, including expenditures for distribution equipment and facility improvements.
Spending in 2013 included plant and equipment constructed to provide oxygen for coal gasification in China, hydrogen to the global market, and renewable energy in the U. K.  In 2013, we completed three acquisitions with an aggregate cash use, net of cash acquired, of $224.9.
In the fourth quarter, we acquired an air separation unit and integrated gases liquefier in Guiyang, China.
During the third quarter, we acquired EPCO, the largest independent U. S.  producer of liquid carbon dioxide (CO2), and WCG.
In 2012, we acquired a controlling stake in Indura S. A.  for $690 and E. I.  DuPont de Nemours and Co. , Inc. ’s 50% interest in our joint venture, DA NanoMaterials for $147.
We also purchased a 25% equity interest in Abdullah Hashim Industrial Gases & Equipment Co.  Ltd.  (AHG), an unconsolidated affiliate, for $155 in the third quarter.
PRUDENTIAL FINANCIAL, INC.  Notes to Consolidated Financial Statements 13.
STOCKHOLDERS’ EQUITY (continued) to support the Closed Block for regulatory purposes.
Dividends on the Class B Stock are payable in an aggregate amount per year at least equal to the lesser of (1) a Target Dividend Amount of $19.25 million or (2) the CB Distributable Cash Flow for such year, which is a measure of the net cash flows of the Closed Block Business.
Notwithstanding this formula, as with any common stock, Prudential Financial retains the flexibility to suspend dividends on the Class B Stock; however, if CB Distributable Cash Flow exists and Prudential Financial chooses not to pay dividends on the Class B Stock in an aggregate amount at least equal to the lesser of the CB Distributable Cash Flow or the Target Dividend Amount for any period, then cash dividends cannot be paid on the Common Stock with respect to such period.
Preferred Stock Prudential Financial adopted a shareholder rights plan (the “rights plan”) under which each outstanding share of Common Stock is coupled with a shareholder right.
The rights plan is not applicable to any Class B Stock.
Each right initially entitles the holder to purchase one one-thousandth of a share of a series of Prudential Financial preferred stock upon payment of the exercise price.
At the time of the demutualization, the Board of Directors of Prudential Financial determined that the initial exercise price per right is $110, subject to adjustment from time to time as provided in the rights plan.
There was no preferred stock outstanding at December 31, 2006 and 2005.
Comprehensive Income The components of comprehensive income for the years ended December 31, are as follows:
## Table 1 ##
(1) Includes cash flow hedges.
See Note 19 for information on cash flow hedges.
The balance of and changes in each component of “Accumulated other comprehensive income (loss)” for the years ended December 31, are as follows (net of taxes):
## Table 2 ##
(1) Includes cash flow hedges.
See Note 19 for information on cash flow hedges.
(2) Net unrealized investment gains (losses) for 2004 include the impact of cumulative effect of accounting change of $73 million.
(3) See Note 16 for additional information on the adoption of SFAS No.158.
PART II ITEM 8 Financial Statements and Supplementary Data

Tables referenced above, in order (Table 0 first):
<table><tr><td></td><td>2013</td><td>2012</td><td>2011</td></tr><tr><td>Additions to plant and equipment</td><td>$1,524.2</td><td>$1,521.0</td><td>$1,309.3</td></tr><tr><td>Acquisitions, less cash acquired</td><td>224.9</td><td>863.4</td><td>10.8</td></tr><tr><td>Investments in and advances to unconsolidated affiliates</td><td>-1.3</td><td>175.4</td><td>45.8</td></tr><tr><td>Capital Expenditures on a GAAP Basis</td><td>$1,747.8</td><td>$2,559.8</td><td>$1,365.9</td></tr><tr><td>Capital lease expenditures<sup>(A)</sup></td><td>234.9</td><td>212.2</td><td>173.5</td></tr><tr><td>Noncurrent liability related to purchase of shares from noncontrolling interests<sup>(A)</sup></td><td>14.0</td><td>6.3</td><td>—</td></tr><tr><td>Capital Expenditures on a Non-GAAP Basis</td><td>$1,996.7</td><td>$2,778.3</td><td>$1,539.4</td></tr></table>
<table><tr><td></td><td>2006</td><td>2005</td><td>2004</td></tr><tr><td></td><td colspan="3">(in millions)</td></tr><tr><td>Net income</td><td>$3,428</td><td>$3,540</td><td>$2,256</td></tr><tr><td>Other comprehensive income (loss), net of tax:</td><td></td><td></td><td></td></tr><tr><td>Change in foreign currency translation adjustments</td><td>197</td><td>-401</td><td>327</td></tr><tr><td>Change in net unrealized investments gains (losses)(1)</td><td>-405</td><td>-445</td><td>-627</td></tr><tr><td>Additional minimum pension liability adjustment</td><td>49</td><td>-111</td><td>-28</td></tr><tr><td>Cumulative effect of accounting change</td><td>—</td><td>—</td><td>73</td></tr><tr><td>Other comprehensive loss, net of tax benefit of $264, $371, $461</td><td>-159</td><td>-957</td><td>-255</td></tr><tr><td>Comprehensive income</td><td>$3,269</td><td>$2,583</td><td>$2,001</td></tr></table>
<table><tr><td></td><td colspan="5">Accumulated Other Comprehensive Income (Loss)</td></tr><tr><td></td><td>Foreign Currency Translation Adjustments</td><td>Net Unrealized Investment Gains (Losses)(1)</td><td>Additional Minimum Pension Liability Adjustment</td><td>Pension and Postretirement Unrecognized Net Periodic Benefit (Cost)</td><td>Total Accumulated Other Comprehensive Income(Loss)</td></tr><tr><td></td><td colspan="5">(in millions)</td></tr><tr><td>Balance, December 31, 2003</td><td>$-1</td><td>$2,575</td><td>$-128</td><td>$—</td><td>$2,446</td></tr><tr><td>Change in component during year-2</td><td>327</td><td>-554</td><td>-28</td><td>—</td><td>-255</td></tr><tr><td>Balance, December 31, 2004</td><td>326</td><td>2,021</td><td>-156</td><td>—</td><td>2,191</td></tr><tr><td>Change in component during year</td><td>-401</td><td>-445</td><td>-111</td><td>—</td><td>-957</td></tr><tr><td>Balance, December 31, 2005</td><td>-75</td><td>1,576</td><td>-267</td><td>—</td><td>1,234</td></tr><tr><td>Change in component during year</td><td>197</td><td>-405</td><td>49</td><td>—</td><td>-159</td></tr><tr><td>Impact of adoption of SFAS No. 158-3</td><td>—</td><td>—</td><td>218</td><td>-774</td><td>-556</td></tr><tr><td>Balance, December 31, 2006</td><td>$122</td><td>$1,171</td><td>$—</td><td>$-774</td><td>$519</td></tr></table>

Question: What will Net income reach in 2007 if it continues to grow at the same growth rate in 2006? (in million)
Answer: 3319.54
Reasoning program: subtract(3428,3540), divide(#0,3540), add(1,#1), multiply(3428,#2)